BIOCRYST PHARMACEUTICALS, INC. Line of Credit, Current
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Line of Credit, Current of $0 as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2021-03-01
- 2020-12-31: Line of Credit, Current $0.00.
- 2020-09-30: Line of Credit, Current $19.15M.
- 2020-06-30: Line of Credit, Current $19.06M.
- 2020-03-31: Line of Credit, Current $14.03M.
| Period end | Line of Credit, Current |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2020-09-30 | $19.15M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $19.06M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $14.03M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $9.02M 10-K · filed 2021-03-01 |
| 2019-09-30 | $4.04M 10-Q · filed 2019-11-08 |
| 2018-12-31 | $4.58M 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.62M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.53M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $6.50M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $6.46M 10-K · filed 2019-03-14 |
| 2017-09-30 | $4.73M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $3.00M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $1.28M 10-Q · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |